[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:ige":3},{"name":4,"total":5,"recruiting":6,"trials":7},"IgE",15,11,[8,16,22,28,34,40,46,52,59,65,70,76,83,91,98],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT06934200","Omalizumab for the Treatment of Food Allergy in Patients With Elevated Total IgE Levels",[12],"Phase 2","RECRUITING","2026-08-26T02:17:30.961790Z","2026-05-05T02:43:29.523410Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT06372249","A Clinical Trial of Soluble Fiber for Asthma",[12],"2026-08-26T02:17:26.640202Z","2026-05-05T02:43:28.121144Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":26,"content_modified":27},"NCT06943534","Omalizumab Weight-Based Dosing Efficacy Trial",[12],"2026-08-26T02:19:12.219640Z","2026-05-05T02:43:27.917430Z",{"nct_id":29,"title":30,"phases":31,"status":13,"updated_at":32,"content_modified":33},"NCT07059091","Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD",[12],"2026-08-26T02:16:20.336282Z","2026-05-05T02:43:27.641238Z",{"nct_id":35,"title":36,"phases":37,"status":13,"updated_at":38,"content_modified":39},"NCT05551793","Regeneron AA Multicenter (Dupilumab)",[12],"2026-08-26T02:18:07.037408Z","2026-05-05T02:35:31.712964Z",{"nct_id":41,"title":42,"phases":43,"status":13,"updated_at":44,"content_modified":45},"NCT05332067","Omalizumab Before Onset of Exacerbations",[12],"2026-08-26T02:19:08.862440Z","2026-04-29T02:57:57.107344Z",{"nct_id":47,"title":48,"phases":49,"status":13,"updated_at":50,"content_modified":51},"NCT07220811","Phase 2b Study of RPT904 as Monotherapy in Participants With IgE-Mediated Food Allergy",[12],"2026-08-26T02:19:13.549512Z","2026-05-05T02:35:31.860366Z",{"nct_id":53,"title":54,"phases":55,"status":13,"updated_at":57,"content_modified":58},"NCT07287033","Study to Evaluate the Safety, Pharmacokinetic, and Pharmacodynamic Effects of MY006 in Healthy Volunteers and Patients With Peanut Allergy",[56],"Phase 1","2026-08-26T02:16:10.529598Z","2026-05-05T02:43:27.405879Z",{"nct_id":60,"title":61,"phases":62,"status":13,"updated_at":63,"content_modified":64},"NCT03835767","Food-Specific and Component IgE Threshold Levels That Predict Food Allergy in People With Elevated Total Serum IgE Levels and Atopic Dermatitis",[12],"2026-08-26T02:18:13.438956Z","2026-05-05T02:43:27.662537Z",{"nct_id":66,"title":67,"phases":68,"status":13,"updated_at":38,"content_modified":69},"NCT06456541","Infant Formula in Infants and Children With Cow's Milk Allergy",[],"2026-07-19T19:36:05.130210Z",{"nct_id":71,"title":72,"phases":73,"status":13,"updated_at":74,"content_modified":75},"NCT06300697","Michigan Food and Atopic Dermatitis (M-FAD) Program - Molecular Analytics Project",[],"2026-08-26T02:17:00.709807Z","2026-05-05T02:43:27.831530Z",{"nct_id":77,"title":78,"phases":79,"status":80,"updated_at":81,"content_modified":82},"NCT07611435","Beginning to Assess an Appropriate CONtrol for Oral Food Challenges in Alpha-Gal Syndrome (CoFAR-13) - BeACON4AG",[12],"NOT_YET_RECRUITING","2026-08-26T02:16:05.813655Z","2026-05-29T15:36:40.229725Z",{"nct_id":84,"title":85,"phases":86,"status":88,"updated_at":89,"content_modified":90},"NCT06191315","Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma\u002FAsthmatic Wheeze Aged 2 to \u003C6 Years (LIBERTY ASTHMA TREKIDS)",[87],"Phase 3","ENROLLING_BY_INVITATION","2026-08-26T02:15:44.309045Z","2026-05-05T02:43:28.848498Z",{"nct_id":92,"title":93,"phases":94,"status":95,"updated_at":96,"content_modified":97},"NCT06339008","A Study of Lebrikizumab in Adult Participants With Perennial Allergic Rhinitis (PREPARED-1)",[87],"ACTIVE_NOT_RECRUITING","2026-08-03T03:07:45.344605Z","2026-05-05T02:43:27.288292Z",{"nct_id":99,"title":100,"phases":101,"status":95,"updated_at":102,"content_modified":103},"NCT07003919","Safety Study of Viaskin® Peanut Patch in Peanut-Allergic Children 1 Through 3 Years of Age (COMFORT Toddlers)",[87],"2026-08-03T02:11:55.742298Z","2026-05-05T02:35:31.616602Z"]